Ying Cheng

2.5k total citations · 1 hit paper
55 papers, 1.9k citations indexed

About

Ying Cheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ying Cheng has authored 55 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Ying Cheng's work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Ying Cheng is often cited by papers focused on MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Ying Cheng collaborates with scholars based in China, United States and Australia. Ying Cheng's co-authors include Liming Chen, Bei Sun, Mei Xue, Yunhong Lu, Xiaochen Yu, Fei Han, Siyuan Zhou, Linxin Xu, Bang‐Le Zhang and Daozhou Liu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ying Cheng

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

2019 442 citations Mei Xue, Xiaoyu Li et al. profile →

Peers

Countries citing papers authored by Ying Cheng

Since Specialization

Citations

This map shows the geographic impact of Ying Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cheng more than expected).

Fields of papers citing papers by Ying Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cheng. The network helps show where Ying Cheng may publish in the future.

Co-authorship network of co-authors of Ying Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Cheng. A scholar is included among the top collaborators of Ying Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Cheng. Ying Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of chronic low-grade inflammation in the development of sarcopenia: Advances in molecular mechanisms 2025 ·International Immunopharmacology ·Ying Cheng, (unknown), Ziyi Cao, (unknown), Yongqian Fan, Jie Chen	15
2	Marine sponge-derived natural products: trends and opportunities for the decade of 2011-2020 2024 ·Frontiers in Marine Science ·(unknown), Qi Yang, Ying Cheng, Christopher M. M. Franco, Wei Zhang	8
3	The recent development, application, and future prospects of muscle atrophy animal models 2024 ·SHILAP Revista de lepidopterología ·Gongchang Zhang, Fengjuan Hu, (unknown), Xiaoqing Ma, Ying Cheng, Xiaolei Liu, Wei Jiang, Birong Dong, Chenying Fu	2
4	The Mitochondria‐Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation 2024 ·Small ·(unknown), Daozhou Liu, (unknown), Miao Liu, Qifeng Ji, Bang‐Le Zhang, Zhifu Yang, Ying Cheng, Siyuan Zhou	10
5	Urinary microbiota and metabolic signatures associated with inorganic arsenic-induced early bladder lesions 2023 ·Ecotoxicology and Environmental Safety ·(unknown), Ying Cheng, Xiaolin Tian, Jia Li, (unknown), (unknown), (unknown), Yan Liu, Yulan Qiu, Xiaoyan Yan, Xuefeng Ren	9
6	A Novel Method for Monitoring N-Nitrosamines Impurities Using NH2-MIL-101(Fe) Mediated Dispersive Micro-Solid Phase Extraction Coupled with LC-MS/MS in Biopharmaceuticals 2023 ·Journal of Pharmaceutical Sciences ·(unknown), Lei Zhang, Wei Hou, Ying Cheng, Feifei Luo, (unknown), (unknown)	6
7	Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway 2022 ·Frontiers in Physiology ·Xiaochen Yu, Ziyu Meng, Ting Fang, Xiaohuan Liu, Ying Cheng, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Ting Li, Bei Sun, Liming Chen	12
8	PACS-2 attenuates diabetic kidney disease via the enhancement of mitochondria-associated endoplasmic reticulum membrane formation 2021 ·Cell Death and Disease ·Mei Xue, Ting Fang, (unknown), Ying Cheng, Ting Li, Chaofei Xu, Chao Tang, Xiaohuan Liu, Bei Sun, Liming Chen	42
9	FG-4592 alleviates radiation-induced intestinal injury by facilitating recovery of intestinal stem cell and reducing damage of intestinal epithelial 2021 ·Toxicology Letters ·(unknown), Yajie Yang, (unknown), (unknown), (unknown), Haibo Tang, (unknown), Ying Cheng, Jianming Cai, Hao Hu, Cong Liu, (unknown), Hu Liu	9
10	Disturbance of the Dlk1-Dio3 imprinted domain may underlie placental Dio3 suppression and extracellular thyroid hormone disturbance in placenta-derived JEG-3 cells following decabromodiphenyl ether (BDE209) exposure 2021 ·Toxicology ·(unknown), Ying Cheng, (unknown), Ruijun Wang, Ruonan Wang, (unknown), Sisi Li, Ye Wang, Yachen Li, Xiaohui Liu, Jing Shao	7
11	The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway 2021 ·International Immunopharmacology ·Ziyu Meng, Xiaohuan Liu, Ting Li, Ting Fang, Ying Cheng, Liping Han, Bei Sun, Liming Chen	86
12	General principles of developing novel radioprotective agents for nuclear emergency 2020 ·SHILAP Revista de lepidopterología ·(unknown), Pei Zhang, Ying Cheng, (unknown), Hu Liu, Fu Gao, Chunmeng Shi, Cong Liu	7
13	Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice 2020 ·International Journal of Biological Sciences ·Yunhong Lu, Yunpeng Chang, Ting Li, Fei Han, Chunjun Li, (unknown), Mei Xue, Ying Cheng, Ziyu Meng, Zhe Han, Bei Sun, Liming Chen	90
14	Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice 2019 ·Clinical Science ·Mei Xue, Ting Li, Yue Wang, Yunpeng Chang, Ying Cheng, Yunhong Lu, Xiangyang Liu, Linxin Xu, Xiaoyu Li, Xiaochen Yu, Bei Sun, Liming Chen	85
15	Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats 2019 ·Journal of Nanobiotechnology ·(unknown), Ying Cheng, Daozhou Liu, Miao Liu, Han Cui, Bang‐Le Zhang, Qibing Mei, Siyuan Zhou	180
16	Role of astrocytes-derived d-serine in PFOS-induced neurotoxicity through NMDARs in the rat primary hippocampal neurons 2019 ·Toxicology ·Ruijun Wang, (unknown), Xiaoying Niu, Ying Cheng, (unknown), Yachen Li, Shuangyue Li, Xiaohui Liu, Jing Shao	24
17	Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease 2018 ·International Journal of Biological Sciences ·Mei Xue, Ying Cheng, Fei Han, Yunpeng Chang, Yang� Yang, Xiaoyu Li, Li Chen, Yunhong Lu, Bei Sun, Liming Chen	93
18	Correlation between peak intensity of contrast enhanced ultrasound and injury severity after liver ischemia reperfusion 2017 ·(unknown), Ying Cheng, Lei Yang	0
19	Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition 2016 ·Cancer Biotherapy and Radiopharmaceuticals ·Xiaofang Zhao, (unknown), (unknown), Bin Xiao, Ying Cheng, Chunhong Feng, Chunyan Duan, Chunyan Zhang, Youping Liu, Hong Li, Bo Xiao, Rongyang Dai	14
20	Assessment of the effects of Radix Bupleuri and vinegar-baked Radix Bupleuri on cytochrome 450 activity by a six-drug cocktail approach 2013 ·Chinese Journal of Natural Medicines ·Ying Cheng, Yin Huang, Yuan Tian, Lei Xu, Guoqiang Liu, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact